These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Decreased polymorphonuclear leucocyte chemotactic response to leukotriene B4 in cystic fibrosis. Lawrence RH; Sorrelli TC Clin Exp Immunol; 1992 Aug; 89(2):321-4. PubMed ID: 1322257 [TBL] [Abstract][Full Text] [Related]
46. In vivo chemotaxis of bovine neutrophils induced by 5-lipoxygenase metabolites of arachidonic and eicosapentaenoic acid. Heidel JR; Taylor SM; Laegreid WW; Silflow RM; Liggitt HD; Leid RW Am J Pathol; 1989 Mar; 134(3):671-6. PubMed ID: 2538061 [TBL] [Abstract][Full Text] [Related]
47. Leukotriene B4-activated human endothelial cells promote transendothelial neutrophil migration. Nohgawa M; Sasada M; Maeda A; Asagoe K; Harakawa N; Takano K; Yamamoto K; Okuma M J Leukoc Biol; 1997 Aug; 62(2):203-9. PubMed ID: 9261334 [TBL] [Abstract][Full Text] [Related]
48. Leukotriene B4 stimulates human polymorphonuclear leukocytes to synthesize and release interleukin-8 in vitro. McCain RW; Holden EP; Blackwell TR; Christman JW Am J Respir Cell Mol Biol; 1994 Jun; 10(6):651-7. PubMed ID: 8003341 [TBL] [Abstract][Full Text] [Related]
49. Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Lee TH; Horton CE; Kyan-Aung U; Haskard D; Crea AE; Spur BW Clin Sci (Lond); 1989 Aug; 77(2):195-203. PubMed ID: 2548801 [TBL] [Abstract][Full Text] [Related]
51. Dietary n-3 fatty acids accelerate catabolism of leukotriene B4 in human granulocytes. von Schacky C; Kiefl R; Marcus AJ; Broekman MJ; Kaminski WE Biochim Biophys Acta; 1993 Feb; 1166(1):20-4. PubMed ID: 8381674 [TBL] [Abstract][Full Text] [Related]
52. The leukotriene B Deng B; Lin Y; Ma S; Zheng Y; Yang X; Li B; Yu W; Xu Q; Liu T; Hao C; He R; Ding F Kidney Int; 2017 Jul; 92(1):89-100. PubMed ID: 28318626 [TBL] [Abstract][Full Text] [Related]
53. Inhibitory effect of loratadine on leukotriene B4 production by neutrophils either alone or during interaction with human airway epithelial cells. Amsellem C; Czarlewski W; Lagarde M; Pachéco Y Pulm Pharmacol Ther; 1998; 11(4):245-52. PubMed ID: 10101740 [TBL] [Abstract][Full Text] [Related]
54. Leukotriene B4 is an incomplete agonist for the activation of human neutrophils. Prescott SM; Zimmerman GA; Seeger AR Biochem Biophys Res Commun; 1984 Jul; 122(2):535-41. PubMed ID: 6087805 [TBL] [Abstract][Full Text] [Related]
56. The in vivo effect of leukotriene B4 on polymorphonuclear leukocytes and the microcirculation. Comparison with activated complement (C5a des Arg) and enhancement by prostaglandin E2. Movat HZ; Rettl C; Burrowes CE; Johnston MG Am J Pathol; 1984 May; 115(2):233-44. PubMed ID: 6326579 [TBL] [Abstract][Full Text] [Related]
57. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies. Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783 [TBL] [Abstract][Full Text] [Related]
58. Comparison of leukotriene B4-induced neutrophil migration through different cellular barriers. Casale TB; Abbas MK Am J Physiol; 1990 Apr; 258(4 Pt 1):C639-47. PubMed ID: 2159214 [TBL] [Abstract][Full Text] [Related]
59. Pharmacological profiles of a potential LTB4-antagonist, SM-9064. Namiki M; Igarashi Y; Sakamoto K; Nakamura T; Koga Y Biochem Biophys Res Commun; 1986 Jul; 138(2):540-6. PubMed ID: 3017332 [TBL] [Abstract][Full Text] [Related]
60. Structure/activity relationship of leukotriene B4 and its structural analogues in chemotactic, lysosomal-enzyme release and receptor-binding assays. Soyombo O; Spur BW; Soh C; Lee TH Eur J Biochem; 1993 Nov; 218(1):59-66. PubMed ID: 8243477 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]